← All companies

VCYT

Veracyte, Inc.

VCYT Nasdaq Services-Medical Laboratories EDGAR ↗

$44.85

-14.93 -24.97%

Key statistics

from XBRL data in SEC filings

Market cap

$3.61B

Revenue (TTM)

$562M

Net income (TTM)

$115M

EPS (TTM)

$1.40

P/E ratio

32.0

Dividend yield

—

Free cash flow

$127M

Cash

$300M

Total assets

$1.49B

Gross margin

71.7%

52-week range

$23.35 – $60.91

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-06-30 Jul 31, 2026 8-K Results of operations (earnings release) Jul 30, 2026 8-K Director or officer change; Shareholder vote results Jun 11, 2026 10-Q Quarter ended 2026-03-31 May 6, 2026 8-K Results of operations (earnings release) May 5, 2026 8-K Director or officer change Mar 16, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 25, 2026 8-K Results of operations (earnings release) Jan 12, 2026 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release) Nov 4, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 6, 2025 8-K Director or officer change; Shareholder vote results Jun 18, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 7, 2025 10-K Fiscal year ended 2024-12-31 Feb 28, 2025 8-K Results of operations (earnings release) Feb 24, 2025 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 6, 2024 8-K Director or officer change Sep 4, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024 8-K Results of operations (earnings release) Aug 6, 2024 8-K Director or officer change; Shareholder vote results Jun 13, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Results of operations (earnings release) May 7, 2024 8-K/A Apr 17, 2024 8-K Other events Mar 22, 2024 8-K Other events Feb 29, 2024 10-K Fiscal year ended 2023-12-31 Feb 29, 2024 8-K Results of operations (earnings release) Feb 22, 2024 8-K Director or officer change Feb 13, 2024 8-K Completed an acquisition or disposition; Unregistered sale of equity Feb 6, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Jan 8, 2024 10-Q Quarter ended 2023-09-30 Nov 8, 2023 8-K Results of operations (earnings release) Nov 7, 2023 10-Q Quarter ended 2023-06-30 Aug 9, 2023 8-K Results of operations (earnings release); Director or officer change Aug 8, 2023 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results Jun 9, 2023 10-Q Quarter ended 2023-03-31 May 5, 2023